干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 416654|回复: 246
go

实时定量pcr [复制链接]

Rank: 1

积分
威望
0  
包包
8  
楼主
发表于 2012-5-17 17:06 |只看该作者 |倒序浏览 |打印
Real-time quantification of microRNAs by
* ]/ d) O9 _6 r8 p5 H8 `8 Fstem–loop RT–PCR' n9 M, F1 P+ t  t2 X& f9 e* t8 x
Caifu Chen*, Dana A. Ridzon, Adam J. Broomer, Zhaohui Zhou, Danny H. Lee,/ u4 L) x( g% r  p3 n; S
Julie T. Nguyen, Maura Barbisin, Nan Lan Xu, Vikram R. Mahuvakar, Mark R. Andersen,# z& V' A1 L+ ~' ~, L
Kai Qin Lao, Kenneth J. Livak and Karl J. Guegler( g' ~+ M" h- H* w
Applied Biosystems, 850 Lincoln Centre Drive, Foster City, CA 94404, USA
) Q6 ~* U: C8 l" ~  e' O5 Z4 }& K/ ^& yReceived May 24, 2005; Revised July 8, 2005; Accepted October 25, 20057 i+ V, J4 z7 [8 ?
ABSTRACT
0 x! M. E) G( U+ g4 K6 E1 u/ ]' K& R0 NA novel microRNA (miRNA) quantification method
+ g8 z6 p! s7 s1 jhas been developed using stem–loop RT followed$ u/ ]; O+ t' _8 S7 e9 \
by TaqMan PCR analysis. Stem–loop RT primers are
  H" C# ?9 B4 f' d. B  d+ J9 }5 P! H3 J9 ^better than conventional ones in terms of RT efficiency
, [) O+ V, \8 L8 E2 Hand specificity. TaqMan miRNA assays are specific0 y3 q$ H4 x: l. }2 t
for mature miRNAs and discriminate among
9 y$ y1 U- F# k/ D/ Y# {related miRNAs that differ by as little as one nucleotide.  T4 q6 D9 d, f& h* l& [
Furthermore, they are not affected by genomic6 m7 y7 D( D  Q5 c7 @
DNA contamination. Precise quantification is
' L- f) \$ T- S$ d7 z! aachieved routinely with as little as 25 pg of total+ l9 L& T* J$ a; }( f; k
RNA for most miRNAs. In fact, the high sensitivity," {! ^* _2 \& k9 g/ f0 |
specificity and precision of this method allows for
( ]0 x9 a; m! x. z  ^direct analysis of a single cell without nucleic acid7 G6 @4 a/ O5 B2 n. b4 x+ J
purification. Like standard TaqMan gene expression
$ c: J+ k! W/ a5 u! Q8 oassays, TaqMan miRNA assays exhibit a dynamic4 c0 l! ?4 p5 m3 K: s) E6 e. p2 ?
range of seven orders of magnitude. Quantification
) d2 r0 o9 e  m1 Cof five miRNAs in seven mouse tissues showed variation' E, r. a: V6 q, N3 I
from less than 10 to more than 30 000 copies per1 l5 B/ s- Z7 n; J' x) ~( ~
cell. This method enables fast, accurate and sensitive; c) L0 E. l+ n" i. K& o
miRNA expression profiling and can identify and; c# _4 ^. v) f6 y
monitor potential biomarkers specific to tissues or( b1 R9 v+ M' J8 [6 q% {
diseases. Stem–loop RT–PCR can be used for the
- l' p! ^) C9 v, z5 squantification of other small RNA molecules such
: l4 e: x1 }) x$ f, {2 Das short interfering RNAs (siRNAs). Furthermore, the
8 `; _- X" h8 c4 o, s: n6 b3 Y8 i) p1 e  b: Wconcept of stem–loop RT primer design could be
  I9 u+ ?/ P1 b: p" F* ]applied in small RNA cloning and multiplex assays
6 O% V2 R+ T2 J) K( Yfor better specificity and efficiency.. x6 e8 P2 `# h0 y) l$ {7 w7 }- C2 K# I
INTRODUCTION
# q* Z2 ~# w1 o$ @MicroRNAs (miRNAs) are naturally occurring, highly conserved1 H, X; i  q% c/ c
families of transcripts (18–25 nt in length) that are
! ~9 D3 i7 `2 C: V4 s; Z+ fprocessed from larger hairpin precursors (1,2). miRNAs are
7 @1 h2 k  a5 z/ k, ^found in the genomes of animals (3–9) and plants (10–12). To) z4 {# D! _; D, H- j& a6 ^8 O
date, there are 1000 unique transcripts, including 326 human0 _; o, V, x" J: E7 n. O
miRNAs in the Sanger Center miRNA registry (13).
+ {3 k7 D5 M5 r6 c- ~4 h* dmiRNAs regulate gene expression by catalyzing the cleavage
4 `2 E6 A! o  ?- y4 R, Nof messenger RNA (mRNA) (14–19) or repressing mRNA3 L' ?/ F2 R$ a9 ~
translation (19–21). They are believed to be critical in cell
, |2 r' Y, y6 F, C+ t; B+ _development, differentiation and communication (2). Specific3 i, N8 l4 ]' X  R4 Y: ~4 z- d% q
roles include the regulation of cell proliferation and metabolism
" d9 c1 p, `+ H(22), developmental timing (23,24), cell death (25),. r0 C  w( q5 B8 U
haematopoiesis (26), neuron development (27), human$ S/ ^9 ^+ K) n/ T
tumorigenesis (28) and DNA methylation and chromatin5 F# s3 o# l' X4 t
modification (29).; f/ ?! \: w6 n0 ~5 I  _
Although miRNAs represent a relatively abundant class of6 ~, j2 O, W; I: M3 D) ]0 w, o
transcripts, their expression levels vary greatly among species
  M0 S; E2 c5 O; C5 d5 |and tissues (30). Less abundant miRNAs routinely escape
+ L# ^+ \3 u' j1 z, j! K9 o! a8 vdetection with technologies such as cloning, northern hybridization# [  [' C8 g, S/ q, U
(31) and microarray analysis (32,33). Here, we present
' v: p8 w% ~0 ?0 F3 z# k! ma novel real-time quantification method for accurate and sensitive
" x8 T" I( t$ o# y% u/ B: N9 S& R0 |detection of miRNAs and other small RNAs. This method7 x0 N* X, A5 j+ M# e0 D$ i
expands the real-time PCR technology for detecting gene
2 x3 E% h4 I9 Qexpression changes from macromolecules (e.g. mRNAs) to
9 V2 m( l% u! n! V0 bmicro molecules (e.g. miRNAs).3 p2 L+ P- T& i1 Z
MATERIALS AND METHODS- G1 W/ L. T8 ]
Targets, primers and probes (Supplementary Data)
7 p! \3 i# d" r& ~! g( rSeventeen miRNA genes were selected from the Sanger
. G3 H* h) W+ P/ sCenter miRNA Registry at http://www.sanger.ac.uk/Software/
/ F4 w6 g: E1 ^1 uRfam/mirna/index.shtml. All TaqMan miRNA assays are
4 z4 {7 R- P. B/ l( R0 f5 Q& u: vavailable through Applied Biosystems (P/N: 4365409). Standard9 `3 @' _6 A! u, }/ L
TaqMan assays for pri-miRNA precursors, pri-let-7a-3; ]7 \: [: O4 S4 L# Y
and pri-miR-26b and pre-miRNA precursor pre-miR-30a were" o, d+ B8 q' g! L
designed using PrimerExpress software (Applied Biosystems,
( _5 r( Y: v% z1 P6 D# g5 BFoster City, CA). All sequences are available in the
  n$ ~0 K4 T" Tsection of the Supplementary Data. Synthetic miRNA oligonucleotides
0 o8 J4 D- w$ B9 jwere purchased from Integrated DNA Technologies
! }$ b' W3 C. ]" m+ fTissue RNA samples, cells, cell lysates and
% M( q( f! g: d, l2 j8 H  @: ototal RNA preparation" u- w' V' u% b# a: b" |2 y
Mouse total RNA samples from brain, heart, liver, lung,! a- Y2 x, ]9 e
thymus, ovary and embryo at day 10–12 were purchased: D5 z" I+ U! s4 f$ p8 h
from Ambion (P/N: 7810, 7812, 7814, 7816, 7818, 7824,* a2 d, o& }3 r1 c8 P) q. K% G0 G# G
7826 and 7968). Ambion’s mouse total RNAs are derived; v' F; h$ E, e$ W: H
from Swiss Webster mice. All RNA samples were normalized
2 {' o5 z' f$ Q5 i* {% G0 l9 fbased on the TaqMan Gene Expression Assays for human or: b1 D( O& q3 i0 ~; U7 I% Z
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
. ^* Q7 f8 [7 i# l: H: T( Aendogenous controls (P/N: 4310884E and 4352339E, Applied
4 [. ?& C8 H" D0 h/ [; C+ gBiosystems).
, u. w' ~: o. a. U1 ?Two cell lines, HepG2 and OP9, were cultured using( W. U& e2 E3 W1 b% ?+ `
Gibco MEM (P/N: 12492–021, Invitrogen, Carlsbad, CA): K2 Y5 S: s+ m0 A% k" ]3 E
supplemented with 10% fetal bovine serum (FBS) (P/N:
- R! P, X* p6 ?- N. S0 E$ PSH30070.01, HyClone, Logan, UT). Trypsinized cells were' {& @9 m" S; ~: `  ]' b7 `
counted with a hemocytometer. Approximately 2.8 · 106
- _/ f* N3 z  `1 Esuspended cells were pelleted by centrifugation (Allegra 6,
% p. g" d6 z, p, yBeckman Coulter, Fullerton, CA) at 1500 r.p.m. for 5 min,
& s& l& y. U0 N9 R% J; G1 kwashed with 1 ml Dulbecco’s phosphate-buffered saline (PBS)
( |8 U1 y/ b9 iwithout MgCl2 and CaCl2 (P/N: 14190078, Invitrogen, Carlsbad,
1 m( i( M  _4 ]5 q( m9 E7 cCA). The cell pellets were re-suspended in 140 ml PBS- W2 i+ V+ T+ g3 g0 k
and processed with three different sample preparation methods.  r( s5 F1 l# H
With the first method, a 50 ml sample (106 cells) was
/ f7 D& A" b% ~2 x* {/ Emixed with an equal amount of Nucleic Acid Purification
! I& Y% T& T/ y4 q1 ]Lysis Solution (P/N: 4305895; Applied Biosystems) by pipetting' y( h6 f3 S- G% ~1 t
up and down 10 times, and then spun briefly. The lysate
' _! L8 j9 W* Xwas diluted 1/10 with 1 U/ml RNase inhibitor solution (P/N:+ z8 y/ O1 v* J7 O0 z
N8080119; Applied Biosystems) before adding the solution to
% I; ?& \, g( W. \an RT reaction. In the second method, a 50 ml sample (1062 p3 p( ?. z: m. w' B* r; h
cells) was used to purify total RNA using the mirVana! I1 n; m8 M7 G' l* m9 [9 P$ {
miRNA Isolation Kit (P/N: 1560, Ambion, Austin, TX)" K8 U2 ^/ Z+ z& n( G$ C
according to the manufacturer’s protocol. Purified total
* P3 c% j! u* G6 b2 L: HRNA was eluted in 100 ml of elution buffer. The third method) _+ A8 z  s$ T$ f2 o/ C
involved diluting cells 1/2 with 1· PBS, heating at 95C for 5
* k1 a& A& G  ~. E+ O7 Gmin, and immediately chilling on ice before aliquotting directly5 T! {8 w$ |. o3 j
into RT reactions.
; P9 T) U2 N0 z$ K0 \+ mmiRNA detection using mirVana miRNA
+ s/ X1 i% l9 f# O  tdetection kit0 S7 T! {& U( M
Solution hybridization-based miRNA analysis was carried out; K7 e: M/ L. ^% Q; f0 v& W5 L" i
using the mirVana miRNA Detection Kit (Cat. #: 1552,
1 |+ f+ h+ i0 D1 ?Ambion) according to the manufacturer’s protocol. RNA
, D* }  K# e! w/ [- Sprobes were synthesized by IDT. The radioisotope labeled* S6 ]2 U  |0 {  C2 E3 a: c
RNA fragments were detected and quantitated with a Cyclone
& Q9 a8 k% _2 JStorage Phosphor System (PerkinElmer, Boston, MA).( M- j8 M' g5 o* P/ J! H
Reverse transcriptase reactions
2 \, G2 r. S* R/ FReverse transcriptase reactions contained RNA samples
9 g) l. |. l! B$ {including purified total RNA, cell lysate, or heat-treated* ?1 H2 z+ {; ^" S: C: q# C
cells, 50 nM stem–loop RT primer (P/N: 4365386 and
! e  L: P5 z3 r- @3 E4 Q5 o4365387, Applied Biosystems), 1· RT buffer (P/N:; p% x3 T9 W' }- P$ r( ]3 s: p
4319981, Applied Biosystems), 0.25 mM each of dNTPs,
' u7 A7 L: V" k, P1 O3.33 U/ml MultiScribe reverse transcriptase (P/N: 4319983,
  w. e2 H6 C5 G+ o9 W: P! TApplied Biosystems) and 0.25 U/ml RNase inhibitor (P/N:% G5 ^% p& Y. q
N8080119; Applied Biosystems). The 7.5 ml reactions were
5 @6 n6 o8 \8 w, n4 q$ g/ pincubated in an Applied Biosystems 9700 Thermocycler in a
. V7 s7 f6 j" f( A  b3 |4 w96- or 384-well plate for 30 min at 16C, 30 min at 42C, 5 min
3 U& b3 K7 @3 h8 R% Wat 85C and then held at 4C. All Reverse transcriptase reactions,5 t" [$ C& v1 s5 G) R5 t0 ]
including no-template controls and RT minus controls,
9 U; l: T6 P( {3 o+ `& h, Bwere run in duplicate.
  T- u# m& t+ S6 G( R1 P, SPCR
9 k& r7 T0 H1 @* S& V# I8 P9 xReal-time PCR was performed using a standard TaqMan
! I3 P/ p- C( _; a1 x6 DPCR kit protocol on an Applied Biosystems 7900HT Sequence
$ T" d5 Y3 d0 y7 @8 ^) Q: ^/ B* g# nDetection System (P/N: 4329002, Applied Biosystems). The
8 c0 I$ @$ `( h0 M5 S$ J! [10 ml PCR included 0.67 ml RT product, 1· TaqMan Universal
; N% g- R0 q+ a% V6 `3 D7 jPCR Master Mix (P/N: 4324018, Applied Biosystems),. ]. u$ C! B1 z' R7 f: ]1 |
0.2 mM TaqMan probe, 1.5 mM forward primer and 0.7 mM4 f4 S0 A2 a8 N1 F3 q2 d; j
reverse primer. The reactions were incubated in a 384-well& u& n, B" t/ `  J- y! s
plate at 95C for 10 min, followed by 40 cycles of 95C for 15 s3 [& e; ]- H; Q4 T% k% {9 Q
and 60C for 1 min. All reactions were run in triplicate. The
* |/ h: t8 w3 B  L' `3 y) T' `5 ]threshold cycle (CT) is defined as the fractional cycle number5 K0 W- a- a; j2 `& }" C, o) Q
at which the fluorescence passes the fixed threshold. TaqMan
* H. ~* p* a1 \' aCT values were converted into absolute copy numbers using a
7 }7 S* T+ }1 d  @0 t2 w6 _standard curve from synthetic lin-4 miRNA.
8 e# o! a4 w- m7 J: c6 y, pThe method for real-time quantification of pri-miRNA$ e  V2 C' E( w5 P9 _# C1 Z
precursors, let-7a-3 and miR-26b, and pre-miRNA precursor
+ O1 W6 L$ {2 ]6 B+ c; rmiR-30a was described elsewhere (34).0 W, c2 Q# J1 Z) S
RESULTS
8 H  r( k2 Z8 n, N% `We proposed a new real-time RT–PCR scheme for miRNA/ p+ C5 p0 J7 X  S) Z  M
quantification (Figure 1). It included two steps: RT and realtime
+ d; \) p) w7 R0 E  SPCR. First, the stem–loop RT primer is hybridized to a* A2 Q, _* G! ^* }3 X
miRNA molecule and then reverse transcribed with a Multi-8 \$ E# w' V/ k9 ^8 y% l- z
Scribe reverse transcriptase. Next, the RT products are quantified, _. ^9 O" O8 D
using conventional TaqMan PCR.
  g9 ^5 S* D9 Q5 ~' K2 k) ZFigure 1. Schematic description of TaqMan miRNA assays, TaqMan-based
* p& E8 S$ k. N4 m5 kreal-time quantification of miRNAs includes two steps, stem–loop RT and realtime
2 o- a! e8 j2 U0 i7 z: pPCR. Stem–loop RT primers bind to at the 30 portion of miRNA molecules) F3 _& @' N: B$ z, ^  E3 h( ^
and are reverse transcribed with reverse transcriptase. Then, the RT product is) B0 u: {1 W% t0 b+ {! H0 }
quantified using conventional TaqMan PCR that includes miRNA-specific( b, K: @& y& ~% K7 N9 F) N4 ]
forward primer, reverse primer and a dye-labeled TaqMan probes. The purpose
8 ]1 h5 t+ \5 rof tailed forward primer at 50 is to increase its melting temperature (Tm)1 K* }5 c. c: a9 I5 v. ?5 u1 b
depending on the sequence composition of miRNA molecules.The dynamic range and sensitivity of the miRNA quantification5 d! O5 \% l' A; I
scheme were first evaluated using a synthetic cel-lin-4
7 J( s# c( C( T4 n" Ptarget. Synthetic RNA was quantified based on the A260 value5 B; n+ |+ _! h! I  O
and diluted over seven orders of magnitude. The cel-lin-4$ [! D: `) H. ^- z
TaqMan miRNA assay showed excellent linearity between
$ p, {7 D5 r. E2 s* Ythe log of target input and CT value, demonstrating that the3 G1 @4 L/ q  u4 h
assay has a dynamic range of at least 7 logs and is capable of2 Y- `: L2 }2 C5 H
detecting as few as seven copies in the PCR reaction (Figure 2).
7 C5 i; `2 ~4 s& i8 QEight additional miRNA assays were also validated using5 L! v! t% \3 {* {& B
mouse lung total RNA. The RNA input ranged from 0.025 to( t- @2 H/ g1 q0 ~! s
250 ng (Figure 3). The CT values correlated to the RNA input
0 R; q0 j0 k! i$ P4 W( r(R2 > 0.994) over four orders of magnitude. A negative control) Q% ]1 [  ]1 U
assay, cel-miR-2, did not give a detectable signal, even in; y) R7 \) R2 e2 }" Z+ J
reactions with 250 ng mouse total RNA.7 l2 i/ O. A4 Y( h# H  b' ?
The expression profile of five miRNAs was determined in
2 M1 h/ W) u" n& Oseven different mouse tissues to create a miRNA expression
" U2 _4 k! ?6 n: U& V9 d* I+ R* Kmap. The copy number per cell was calculated based on the
$ b# C5 O% i- z( a, P* f" dinput total RNA (assuming 15 pg/cell) and the standard curve. q9 V  i4 u8 ^5 s, T
of synthetic lin-4 target. Several interesting observations were: \5 w' n+ n3 s- t- A
made from this expression map. First, miRNAs are very
& U/ p4 U2 D: B9 S0 A' Wabundant, averaging 2390 copies per cell in these tissues.
% P" R9 r* G) U8 oThe level of expression ranged from less than 10 to 32 090
2 Q2 \6 d) Z! U  r" q" jcopies per cell. Of the 12 miRNAs, miR-16 and miR-323 were
: o) A. q4 m" ethe most and least abundant miRNAs, respectively, across all9 h7 X1 [2 N# v- O/ `5 y
tissues. In addition, each tissue had a distinctive signature of7 Y; g1 e5 L( K  W! B
miRNA expression. The overall level of miRNA expression' I6 @8 j* T; R( A2 b9 I
was highest in mouse lung and lowest in embryos. Finally, the* z; D9 g- B$ `$ ?. d1 s
dynamic range of miRNA expression varied greatly from less
4 v0 h) A) f9 c8 I* Q; I, Rthan 5-fold (let-7a) to more than 2000-fold (miR-323) among& B/ F) p/ M2 H2 U+ |
these seven tissues (Table 1).
" ^4 O/ ?4 L3 D  h7 N: p8 |To assess the need for RNA isolation, we added cell lysates
2 p+ ^5 A+ C+ E' X2 c: @; p3 x7 Fdirectly to miRNA assays. The equivalent of 2.5–2500 cells3 T! c3 g7 v. U
were added directly to 7.5 ml RT reactions. When detected,5 h# `+ @9 F- a, G1 w
the CT values correlated (R2 > 0.998) to the number of cells inthe RT reactions over at least three orders of magnitude
/ H! M! l% `0 F3 Z2 [(Figure 4)., E- ?' M* O7 T# n
The effect of non-specific genomic DNA on TaqMan
8 |, N! p! c3 o% nmiRNA assays was also tested for 12 assays. Results showed
- Y8 p+ Y' H. U) r* sno difference in CT values in the presence or absence of 5 ng of. }! y- F( S! i& k
human genomic DNA added to the RT reactions, suggesting
- Y+ g) ]$ p1 O1 e$ kthat the assays are highly specific for RNA targets (data not
2 I) ~  I1 B  ~/ Z4 Xshown). Based on this observation, we added heat-treated cells
5 ~2 M* p" V1 {0 Rdirectly to miRNA quantification assays. Figure 5 illustrates
) k4 j$ ]% I7 h1 u; Dthe comparison of miRNA quantification using purified totalRNA, cell lysates and heat-treated cells derived from an equal
6 q/ t$ t* `+ P5 E! unumber of HepG2 cells. Adding heat-treated cells directly to
7 D& G; f+ v7 u& Z) {the miRNA assays produced the lowest CT values, and good3 M. W' Y+ a8 x0 o) d! _
concordance was observed among all three different sample1 N$ u; R0 k7 i8 N7 u" T" X4 y
preparation methods.* y( d2 A  G5 H+ p; X3 m3 p
The reproducibility of TaqMan miRNA assays was# M3 J) Y) w$ P1 a. ^& n
examined by performing12 miRNA assays with 16 replicates
; Y8 r: Q' G6 zperformed by two independent operators (data not shown)., z, d  u& S; h: S6 c
The standard deviation of the CTs averaged 0.1, demonstrating
2 l6 h6 c% Y+ T1 e4 J; zthe high precision of the assays.+ |0 C; _$ l% f. E( D
Solution hybridization-based miRNA northern analysis was
& T, ^5 {7 [5 \0 @2 y2 @7 {used as an independent technology to compare with TaqMan
0 a) S% s& U2 H  TmiRNA assays (Figure 6). We observed that hybridizationbased  ]9 }8 C) W. O, D/ q2 D
miRNA analyses were less reproducible and that concordance
& G' w# [, Q' n( G) c0 y/ Nwith TaqMan assays varied from target to target.
! C% [+ f  ^1 `! xThere was a general concordance between the two methods( a3 Q6 m) K; h  I5 T4 v) P
(R2 ¼ 0.916) for miR-16 across five mouse tissue samples.  c5 g' ?/ Z& v& }2 u4 T" j- [$ E& {
However, correlations were relatively low for less abundant3 S8 X1 c* Z: d3 N
miRNAs, such as miR-30 (R2 ¼ 0.751).
( @) M$ c( [5 `. N- MHybridization methods can lack specificity for the mature: |/ D' q4 Y5 |! m
miRNAs. We investigated the ability of the TaqMan miRNA5 m, K9 R6 ]; E) h% L
assays to differentiate between the mature miRNAs and their
' D) z5 o+ I: Blonger precursors, using synthetic targets for pri-miRNA precursors,
8 e% H' D! L, @pri-miR-26b and pri-let-7a and pre-miRNA precursor
7 e% m' G4 R' v' s0 i8 y. h' Bpre-miR-30a (Table 2). TaqMan assays designed to detect9 b+ Q- n- g) s# A
either precursors or mature miRNAs were tested with synthetic
8 s9 ]6 p: t. ^0 g4 \9 {& P+ ptargets averaging 1.5 · 108 copies per RT reaction (1.3 · 1072 w- z8 w. e; O( w
copies per PCR). TaqMan miRNA analyses with only primiRNA
$ h* V* f. H, s2 N8 kprecursor molecules produced CT values at least
& M$ V$ E* D) W11 cycles higher than analyses with mature miRNA ones.9 F0 [' H8 u* U% a  I" s- q% i
This result implies that if mature miRNA and precursor
3 M7 }: o+ ?7 j/ ?* w+ S# ~3 fwere at an equal concentration, the latter would contribute8 v8 H! m, c: c& T
<0.05% background signal to the assay of mature target.( j* o1 L* R/ m$ E. g; N1 W6 A0 t
For pre-miR-30a where the mature miRNA miR-30a-3p is
1 a+ {4 ~9 b* S6 l/ _2 S9 W' qlocated at the 30 end of the pre-miR-30a sequence, a differenceof 8.4 CT was observed. The results showed that TaqMan
9 O) `$ x9 Q% z, C: bmiRNA assays are specific to mature miRNAs. However,. M: h% ~. K, i8 n8 H0 Y; ^2 I
the assay specificity is better if the miRNA is located at the" J. B% Z7 L2 y( U; }5 @( I! o
50 strand of the pre-miRNA precursor. Experiments analyzing% h, F& z2 l3 A" X& R9 r
total RNA instead of synthetic targets indicated that the precursors; Z3 u7 i# [6 j$ g
are at least two orders of magnitude less abundant than
5 P( p. S, W; Q* B0 \" `" l, @mature miRNAs, based on CT differences of 7 or more for
0 Q7 O, R% j) y1 ~% c2 ?miR-26b-1 and let-7a-2 precursors. Considered together, these
# l4 `3 Q. ^9 M- Uresults suggest that the TaqMan miRNA assays are highly
5 Q, `$ v5 g. t" C7 v6 ^specific for the mature miRNAs.
) E. N# u; Q* Z% ?9 h, lThe ability of the TaqMan miRNA assays to discriminate
8 [$ `" [. ?5 p3 }miRNAs that differ by as little as a single nucleotide was tested. C8 d8 x& a6 Q, h
with the five synthetic miRNAs of let-7a, let-7b, let-7c, let-7d
* u8 ]+ v+ \- B" Nand let-7e (Figure 7). Each miRNA assay was examined
/ E  ]" U4 c, g$ _8 O0 \& kagainst each miRNA. Relative detection efficiency was calculated' u( c& ]3 F! x; r  i+ B
from CT differences between perfectly matched and
7 ~+ O* Y! ~; [3 j4 Y4 J7 K) C9 jmismatched targets, assuming 100% efficiency for the perfect
( J( i$ Q4 V+ L: Smatch. Very low levels of non-specific signal were observed,
8 Q2 J% C8 {6 D4 Q$ |; ?( R, Kranging from zero to 0.3% for miRNAs with 2–3 mismatched7 O0 o) C  E3 i3 [" _" ?% n
bases and only 0.1–3.7% for the miRNAs that differed by a' p2 r% {/ f5 y- z9 R1 [. f/ {
single nucleotide. Most cross-reactions resulted from G–T
& \: ~7 e  p; g3 F( Xmismatches during the RT reaction (let-7a assay versus let-: p, v2 h: u- V; {
7c target etc.). Only the targeted miRNA was detected if more
9 [9 U9 a# h7 F* K: ?than three mismatched bases between any two miRNAs were
/ ~0 E/ O& K8 @0 W2 c7 s; J# g& Ipresent.
  y0 B0 c: h) RWe compared the discrimination ability of the TaqMan; E, p( c, u/ O, p9 y
miRNA assays to that of solution-based hybridization analysis
9 ?6 Q8 u& c* I# r! k* C(Figure 8). In our hands, the hybridization method discriminated+ f6 v, [) P1 |: U+ s
well between let-7a and let-7b. However, poor or no
3 v! d9 T4 d- {1 g3 ?/ a# f$ Ddiscrimination was observed among let-7a, let-7c and let-
7 S' U. M4 i$ Z& ~- _7 a& |7d, which differ by 1–3 nt.0 N* ^7 U4 u# z% H
We speculated that stem–loop primers might provide better4 x( k# Y3 V$ n6 d! E9 L
RT efficiency and specificity than linear ones. Base stacking of
$ V6 K% W" d2 a8 Y! }8 `6 Q+ ]the stemmight enhance the thermal stability of the RNA–DNA
# x/ I& B  h' Q% \. e8 qheteroduplex. Furthermore, spatial constraint of the stem–loop
( r7 N% [3 ]# _1 @would likely improve the assay specificity in comparison to
2 Q5 l" t% C% z4 |8 F# N5 ]conventional linear RT primers. We compared the sensitivity* X1 m: z" J- B9 Z2 C
and specificity of the stem–loop and linear RT primers using2 W5 f5 z2 g" u# w7 _" |& ~3 a5 b
synthetic miRNAs for let-7a (Figure 9). We observed several
9 Z, R* z) s# `advantages for the stem–loop RT. First, in the presence of the5 q! ~1 S. Z1 j6 W
synthetic let-7a target, the CT values between linear and stem–
: e# h$ q+ v* x3 O  A( Nloop RT methods differed by 7, indicating that the efficiency of7 E$ A% u  Y" x& \0 F1 u
stem–loop RT was at least 100 times higher. Secondly, stem–" w! }! v; m/ u( H! b1 E) _
loop RT discriminated better between miRNAs that differ by' C3 F; S" r* ]& r  e
two bases based on DCT values. Finally, the stem–loop RT was
8 N# A  m: \, ?  U* ^& s5 xat least 100 times better able to discriminate between the
" ]- P: q- E' v) R& gmature miRNA and its precursor, based on the DCT (precursor
  r* N' y* `& W4 ~- Tversus mature) of 7.
( I6 H9 V/ [6 ~: y! n0 HDISCUSSION( U0 c" e! ^" h2 c
Since the discovery of miRNAs, remarkable advances in the
5 Z, w* Q7 f2 T0 `% t' P- i& E7 Qcharacterization of these gene families have delineated the- p2 d+ e/ v  I- h. T5 s. h
mechanism for their functions in gene regulation (35). As a
- C0 ]$ `/ W# m$ p( ^0 @) J8 a; `; ]result, extensive surveys have begun to identify miRNA biomarkers1 ~, K- p* I* j3 \& j
specific for tissue types or disease status. These studies
4 d7 Q0 f0 u/ @) @7 [9 b3 ~will benefit from methods that allow for both accurate
! \+ y5 n4 m; R: i( E5 Aidentification and quantification of miRNAs.
3 R0 H& {  n; Z* G9 ~Current methods for detection and quantification of miRNAs
' I/ L6 I3 Y4 zare largely based on cloning, northern blotting (5), or
5 _4 B( y6 |$ S+ ?! m$ |primer extension (36). Although microarrays could improve8 ]0 i0 R) R$ ?) n4 R
the throughput of miRNA profiling, the method is relatively% [" h5 ~- m5 Q7 E, b5 v
limited in terms of sensitivity and specificity (32,33). Low
7 M% m' `3 o. D8 lsensitivity becomes a problem for miRNA quantification3 Z2 \, ~+ j4 H5 L
because it is difficult to amplify these short RNA targets.0 ^; e1 l$ y7 M) J7 T& \! G# H9 m
Furthermore, low specificity may lead to false positive signalfrom closely related miRNAs, precursors and genomic
; r- }" J# S% i, L2 h: esequences. More recently, a modified Invader assay has9 o  z7 x" K8 m8 V9 x/ \; C) R7 X
been reported for the quantification of several miRNAs5 k, z. d4 f+ A, }) I1 w" G2 v
(37). However, Invader assays have limited specificity and
; U- i. l: |/ ]sensitivity, requiring at least 50 ng total RNA, or 10000 ?/ Z- C8 i; W0 e0 l- U& q
lysed cells, per assay.
3 q( ]. v6 w  A& XReal-time PCR is the gold standard for gene expression1 `( Y8 G3 s2 P% V
quantification (38,39). It has been a long challenge for scientists$ ~; P6 ~3 J* ?$ y
to design a conventional PCR assay from miRNAs averaging! Q; R' F+ P; `3 c7 w" Y1 L( `
22 nt in length. We developed a novel scheme to% n- G* z. s% x8 F1 F0 q
design TaqMan PCR assays that specifically quantify
1 [: i2 j- Z- L, W' {miRNA expression levels with superior performance over, V; X" X3 b- s
existing conventional detection methods. We have designed
6 i4 t9 H1 c2 `6 V5 m1 d+ P; [- Hand validated assays for 222 human miRNAs (Chen et al.,
6 m2 S: h$ v5 ?6 iunpublished data). These assays combine the power of PCR$ f0 D9 S. l! y& a, x) S& R. c
for exquisite sensitivity, real-time monitoring for a large
2 K! Z1 L( S3 F! odynamic range and TaqMan assay reporters to increase the7 V2 J! T( @' M/ V4 _5 \2 E7 M
specificity. In our hands, miRNA precursors were at least 2000
' v9 N2 b  F, w4 `times less effective targets than mature miRNAs (Table 2).
' x% D2 Y& g; H( {1 lBecause these assays are insensitive to precursors or genomic! x  ^% G2 C( g' [) v6 [+ _
DNA, we were able to add heat-treated cells directly to the
) U6 \+ u; q: l$ b+ T( ]assays, eliminating the need for sample preparation. For" M  G5 W) k6 m; _  }' z0 j
applications where both mature miRNAs and their precursors
6 _! E( [$ E( ~9 M6 O1 ^- nneed to be assayed, conventional TaqMan assays can be used4 |0 o  |5 T2 `) k5 O
in parallel to specifically detected precursors.
, f0 V6 K+ r9 h3 `$ Q2 \We observed the better specificity and sensitivity of stem–2 z/ t: N8 G& v- d5 y
loop RT primers than conventional linear ones likely due to the" j2 L6 q( z% P# G
base stacking and spatial constraint of the stem–loop structure
4 z5 O3 e4 ~, R(Figure 9). The base stacking could improve the thermal stability
; `. N7 A7 W. I; y/ @* Oand extend the effective footprint of RT primer/RNA* d1 A9 Y! c0 [6 \; E* c
duplex that may be required for effective RT from relatively% j; y+ p  |! `1 r. r* b8 N; [! X
shorter RT primers. The spatial constraint of the stem–loop0 p! T" O# N0 k9 I; ?- Z
structure may prevent it from binding double-strand genomic" U- x4 w3 [0 ~; b7 K
DNA molecules and, therefore, eliminate the need of TaqMan9 _. ]/ S8 P+ ^+ w4 I
miRNA assays for RNA sample preparation. Stem–loop
% u8 j# I; L9 j$ \* \+ J! bRT primers can potentially be used for multiplex RT reactions5 y) s* [7 o' D, `
and small RNA cloning for possibly better efficiency and  h  E* i! }1 ]
specificity.5 c& ?1 u* j; M7 u
There is an increasing need for sensitive and specific whole
$ D% R" X: q3 Z+ umiRNA profiling. The ability to effectively profile miRNAs
3 W2 Y+ J1 _0 i* Scould lead to the discoveries of disease- or tissue-specific
6 O* i; l1 n, [( ^3 |- W: }5 XmiRNA biomarkers, as well as contribute to the understanding
  f7 E, V( B7 ~  e3 _2 T4 X. F+ a! fof how miRNAs regulate stem cell differentiation. Our stem–, D, d3 |& B, H* Q9 Z8 q) `( G( F
loop RT–PCR method should provide a practical solution for
! h# K3 W& \% V6 W4 Nthese studies. We are currently developing multiplex7 x3 |6 Y' g' w
approaches that should further increase the utility of this
" R5 D: M6 U" {1 umethod.

Rank: 2

积分
61 
威望
61  
包包
1757  
沙发
发表于 2015-5-26 21:10 |只看该作者
这个贴不错!!!!!  

Rank: 2

积分
116 
威望
116  
包包
1832  
藤椅
发表于 2015-6-4 17:10 |只看该作者
挺好啊  

Rank: 2

积分
122 
威望
122  
包包
1876  
板凳
发表于 2015-7-18 15:44 |只看该作者
干细胞之家微信公众号
一楼的位置好啊..  

Rank: 2

积分
104 
威望
104  
包包
1772  
报纸
发表于 2015-7-21 08:27 |只看该作者
支持你一下下。。  

Rank: 2

积分
61 
威望
61  
包包
1757  
地板
发表于 2015-8-8 19:24 |只看该作者
其实回帖算是一种没德德,所以我快成圣人了  

Rank: 2

积分
64 
威望
64  
包包
1782  
7
发表于 2015-8-29 13:42 |只看该作者
怎么就没人拜我为偶像那?? ~  

Rank: 2

积分
162 
威望
162  
包包
1746  
8
发表于 2015-8-29 16:01 |只看该作者
快毕业了 希望有个好工作 干细胞还是不错的方向

Rank: 2

积分
79 
威望
79  
包包
1769  
9
发表于 2015-9-12 19:01 |只看该作者
我喜欢这个贴子  

Rank: 2

积分
107 
威望
107  
包包
1889  
10
发表于 2015-9-28 20:55 |只看该作者
观看中  
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-6-14 16:48

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.